FDAnews Device Daily Bulletin

LIFETIME WITHOUT COLD SORES WITH INTERCEPTCS

April 7, 2006
A A

The Gibson Group is pleased to announce the launch of interceptCS, an innovative device that completely revolutionizes the management of cold sores (herpes simplex -1). In contrast to other available therapies such as topical or oral antiviral medications, interceptCS doesn't 'treat' cold sores -- it prevents them before they start. CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=588123)